Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing, 210023, China.
Department of Dermatology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Theranostics. 2020 Jul 2;10(18):8061-8079. doi: 10.7150/thno.42284. eCollection 2020.
Noble metal Au nanoparticles have attracted extensive interests in the past decades, due to their size and morphology dependent localized surface plasmon resonances. Their unique optical property, high chemical stability, good biocompatibility, and easy functionalization make them promising candidates for a variety of biomedical applications, including bioimaging, biosensing, and cancer therapy. With the intention of enhancing their optical response in the near infrared window and endowing them with additional magnetic properties, Au nanoparticles have been integrated with other functional nanomaterials that possess complementary attributes, such as copper chalcogenides and magnetic metal oxides. The as constructed hybrid nanostructures are expected to exhibit unconventional properties compared to their separate building units, due to nanoscale interactions between materials with different physicochemical properties, thus broadening the application scope and enhancing the overall performance of the hybrid nanostructures. In this review, we summarize some recent progresses in the design and synthesis of noble metal Au-based hybrid inorganic nanostructures for nanomedicine applications, and the potential and challenges for their clinical translations.
在过去的几十年中,由于其尺寸和形态依赖的局域表面等离子体共振,贵金属 Au 纳米粒子引起了广泛的关注。它们独特的光学性质、高化学稳定性、良好的生物相容性和易于功能化,使它们成为各种生物医学应用的有前途的候选者,包括生物成像、生物传感和癌症治疗。为了增强它们在近红外窗口的光学响应,并赋予它们额外的磁性,Au 纳米粒子已经与具有互补属性的其他功能纳米材料(如铜硫属化物和磁性金属氧化物)集成在一起。由于具有不同物理化学性质的材料之间的纳米级相互作用,所构建的混合纳米结构有望表现出与单独构建单元不同的非常规性质,从而拓宽了应用范围并提高了混合纳米结构的整体性能。在这篇综述中,我们总结了一些关于用于纳米医学应用的贵金属 Au 基混合无机纳米结构的设计和合成的最新进展,以及它们在临床转化方面的潜力和挑战。
Theranostics. 2020
Appl Biochem Biotechnol. 2012-1-26
Curr Top Med Chem. 2016
Nanomedicine (Lond). 2019-5-10
Adv Colloid Interface Sci. 2019-7-17
Curr Med Chem. 2018
Comput Struct Biotechnol J. 2025-5-9
J Nanobiotechnology. 2022-9-29
Int J Nanomedicine. 2022
Nanomaterials (Basel). 2022-4-16
Nanomaterials (Basel). 2021-11-5
Nanomaterials (Basel). 2021-5-6
Theranostics. 2020-5-15
Nanotechnology. 2020-1-24
Nat Mater. 2020-1-13